Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Zinc finger NFX1-type containing 1 (ZNFX1)** is a large, evolutionarily conserved protein encoded by the ZNFX1 gene, featuring a superfamily 1 (SF1) RNA helicase core, six NFX1-type zinc finger domains, an Armadillo-type fold (ARM) domain, a P-loop NTPase domain, a coiled-coil region, and a C-terminal RZ-type zinc finger[1][2][3]. Its main functions include the modulation of innate immune responses—regulating interferon signaling, mRNA stability (notably *Prkaa2*), suppression of excessive inflammation, and acting as a double-stranded RNA sensor in some contexts[1][2][3][4]. It is active in the cytoplasm and membrane, particularly in myeloid cells, and is essential for host defense against both viruses and bacteria (notably Mycobacterium tuberculosis)[1][2][3][5]. Deficiency of ZNFX1 results in a primary immunodeficiency with increased susceptibility to infections and severe systemic inflammation[1][5]. ZNFX1 is not currently a therapeutic target for any drugs, but its critical role in immune regulation makes it a subject of active biomedical research[1][3][5].
Not applicable (no direct drug modulators known as of current literature)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger NFX1-type containing 1 (ZNFX1).